Sidewinder Therapeutics
About Sidewinder Therapeutics
Sidewinder Therapeutics is a biopharmaceutical company focused on developing precision biologics, aiming to deliver large-molecule therapies for cancer and rare diseases. The company emphasizes next-generation precision therapeutics and innovative medicines driven by a team of experienced scientists and drug developers. It highlights leadership in drug discovery and development with a focus on targeted molecular drivers of disease. The organization appears to be based in the United States, with an emphasis on advanced oncology and rare-disease programs.
Recent News
What the Smart Money Just Bought in Healthcare and Life Sciences VC Over the Last Sixty Days
Syneron Raises $150m for Macrocyclics, and Other Financings
Follow the Money: Autoimmune, Inflammatory Disease Therapies, Antibody-Drug Conjugates, AKT1-Selective Inhibitor Programs
Bispecific ADCs and the Conditions Nobody Is Talking About